Review of MammoSite brachytherapy: Advantages, disadvantages and clinical outcomes

References

• Baglan KL, Martinez AA, Frazier RC, Kini VR, Kestin LL, Chen PY, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2001; 50: 1003–11
   PubMed Web of Science ®Google Scholar
• Lawenda BD, Taghian AG, Kachinic LA, Hamdi H, Smith BL, Gadd MA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 2003; 56: 671–80
   PubMed Web of Science ®Google Scholar
• Blichert-Toft M, Rose C, Anderson JA, Overgaard M, Axelsson CK, Andersen LW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992; 11: 19–25
   PubMedGoogle Scholar
• Fisher B, Anderson S, Redmond CK, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333: 1456–61
   PubMed Web of Science ®Google Scholar
• Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92: 1143–50
   PubMedGoogle Scholar
• Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347: 567–75
   PubMed Web of Science ®Google Scholar
• Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227–32
   PubMed Web of Science ®Google Scholar
• Bartelink H, Horiot JC, Poortmans H, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378–87
   PubMed Web of Science ®Google Scholar
• Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002; 80: 121–8
   PubMed Web of Science ®Google Scholar
• Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000; 92: 269–71
   PubMedGoogle Scholar
• Vicini FA, Horwitz EM, Lacerna MD, Dmuchowski CF, Brown DM, White J, et al. Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 1997; 37: 845–52
   PubMed Web of Science ®Google Scholar
• Vicini FA, Kestin LL, Edmundson GK, Jaffray DA, Wong JW, Kini VR, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999; 45: 803–10
   PubMed Web of Science ®Google Scholar
• Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al. Accelerated treatment of breast cancer. J Clin Oncol 2001; 19: 1993–2001
   PubMed Web of Science ®Google Scholar
• Fentiman IS, Poole C, Tong D, Winter PJ, Gregory WM, Mayles HM, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 1996; 32A: 608–11
   PubMed Web of Science ®Google Scholar
• Vicini F, Kini VR, Chen P, Horwitz E, Gustafson G, Benitez P, et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol 1999; 70: 33–40
   PubMed Web of Science ®Google Scholar
• Kestin LL, Jaffray DA, Edmundson GK, Martinez AA, Wong JW, Kini VR, et al. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys 2000; 46: 35–43
   PubMed Web of Science ®Google Scholar
• Major, T, Niehoff, P, Kovacs, G, Fodor, J, Polgar. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol 2006;79:321–8. Epub 2006 May 26.
   PubMed Web of Science ®Google Scholar
• Edmundson GK, Vicini FA, Chen PY, Mitchell C, Martinez AA. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2002; 52: 1132–9
   PubMed Web of Science ®Google Scholar
• Kassas B, Mourtada F, Horton JL, Lane RG. Contrast effects on dosimetry of a partial breast irradiation system. Med Phys 2004; 31: 1976–9
   PubMed Web of Science ®Google Scholar
• Kirk MC, Hsi WC, Chu JC, Niu H, Hu Z, Bernard D, et al. Dose perturbation induced by radiographic contrast inside brachytherapy balloon applicators. Med Phys 2004; 31: 1219–24
   PubMed Web of Science ®Google Scholar
• Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys 2004; 60: 722–30
   PubMed Web of Science ®Google Scholar
• Borg M, Yeoh E, Bochner M, Butters J, Van Doorn T, Farshid G, et al. Feasibility study on the MammoSite in early-stage breast cancer: Initial experience. Australas Radiol 2007; 51: 53–61
   PubMedGoogle Scholar
• Dickler A, Kirk M, Choo J, His WC, Chu J, Dowlatshahi K, et al. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2004; 59: 469–74
   PubMed Web of Science ®Google Scholar
• Weed DW, Edmundson GK, Vicini FA, Chen PY, Martinez AA. Accelerated partial breast irradiation: A dosimetric comparison of three different techniques. Brachytherapy 2005; 4: 121–9
   PubMedGoogle Scholar
• Khan AJ, Kirk MC, Mehta PS, Seif NS, Griem KL, Bernard DA, et al. A dosimetric comparison of three-dimensional conformal, intensity-modulated radiation therapy, and MammoSite partial-breast irradiation. Brachytherapy 2006; 5: 183–8
   PubMed Web of Science ®Google Scholar
• Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 1995; 22: 209–34
   PubMed Web of Science ®Google Scholar
• Mitra RC, Cheng C, Das I. Dose perturbation due to contrast medium in MammoSite: Dosimetric investigation of dose calculation accuracy. Med Phys 2003; 30: 1388
   Google Scholar
• Ye SJ, Brezovich IA, Shen S, Kim S. Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 2004; 60: 672–7
   PubMed Web of Science ®Google Scholar
• Cheng CW, Mitra R, Li XA, Das IJ. Dose perturbations due to contrast medium and air in mammosite treatment: An experimental and Monte Carlo study. Med Phys 2005; 32: 2279–87
   Google Scholar
• Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003; 55: 289–93
   PubMed Web of Science ®Google Scholar
• Niehoff, P, Polgar, C, Ostertag, H, Major, T, Sulyok, Z, Kimmig, B, , et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: Results from an international phase II trial. Radiother Oncol 2006;79:316–20. Epub 2006 Jun 14.
   PubMed Web of Science ®Google Scholar
• Dragun, AE,Harper, JL, Jenrette, JM, Sinha, D, Cole, DJ. Predictors of cosmetic outcome following MammoSite breast brachytherapy: A single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys 2007;68:354–8. Epub 2007 Mar 26.
   PubMed Web of Science ®Google Scholar
• Keisch M, Vicini F, Kuske R, Hebert M, White J, Quiet C, et al. Two-year outcome with the MammoSite breast brachytherapy applicator: Factors associated with optimal cosmetic outcome when performing partial breast irradiation. Int J Radiat Oncol Biol Phys 2003; 57: S315
   Google Scholar
• Keisch M, Vicini F, Scroggins T, Hebert M, White J, Quiet C, et al. Thirty month results with the MammoSite breast brachytherapy applicator: Cosmesis, toxicity and local control in partial breast irradiation. Int J Radiat Oncol Biol Phys 2004; 60: S272
   Google Scholar
• Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 2004; 11: 739–46
   PubMed Web of Science ®Google Scholar
• Shah NM, Tenenholz T, Arthur D, DiPetrillo T, Bornstein B, Cardarelli G, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: Factors that affect toxicity and cosmesis. Cancer 2004; 101: 727–34
   PubMed Web of Science ®Google Scholar
• Dickler A, Kirk MC, Choo J, His WC, Chu J, Dowlatshahi K, et al. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J 2005; 11: 306–10
   PubMed Web of Science ®Google Scholar
• DiFronzo LA, Tsai PI, Hwang JM, Lee JJ, Ryoo MC, Rahimian J, et al. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: Initial clinical experience. Arch Surg 2005; 140: 787–94
   PubMedGoogle Scholar
• Harper JL, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE. Acute complications of MammoSite brachytherapy: A single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 2005; 61: 169–74
   PubMed Web of Science ®Google Scholar
• Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 2005; 104: 1138–48
   PubMed Web of Science ®Google Scholar
• Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, et al. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: A phase II clinical study. Am J Surg 2006; 192: 427–33
   PubMed Web of Science ®Google Scholar
• Jeruss, JS, Vicini, FA, Beitsch, DD, Haffty, BG, Quiet, CA, Zannis, VJ, , et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol 2006;13:967–76. Epub 2006 May 16.
   PubMed Web of Science ®Google Scholar
• Sadeghi A, Prestidge B, Lee JM, Rosenthal A. Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite applicator. Brachytherapy 2006; 5: 230–4
   PubMed Web of Science ®Google Scholar
• Chao, KK, Vicini, FA, Wallace, M, Mitchell, C, Chen, P, Ghilezan, M, , et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: The William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys 2007;69:32–40. Epub 2007 Apr 30.
   PubMed Web of Science ®Google Scholar
• Chen S, Dickler A, Kirk M, Shah A, Jokich P, Solmos G, et al. Patterns of failure after MammoSite brachytherapy partial breast irradiation: A detailed analysis. Int J Radiat Oncol Biol Phys 2007; 69: 25–31
   PubMed Web of Science ®Google Scholar
• Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007; 194: 456–62
   PubMed Web of Science ®Google Scholar
• Agawal, A, Beriwal, S, Heron, D, Falk, J, Johnson, R, Mogus, BM, , et al. Accelerated partial breast irradiation: Single institutional experience of 100 patients using MammoSite brachytherapy. Int J Radiat Oncol Biol Phys 2005;63((Suppl 1))s6–s7.
   Google Scholar
• Evans, SB, Kaufman, SA, Price, LL, Cardarelli, G, DiPetrillo, TA, Wazer, DE, , et al. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: Incidence, pathologic anatomy, and contributing factors. Int J Radiat Oncol Biol Phys 2006;65:333–9. Epub 2006 Mar 20.
   PubMed Web of Science ®Google Scholar